Clinical Trial Details

Overview

Research Study Summary

A research study for patients who are being treated for atrial fibrillation

Purpose

Study Purpose:
To investigate the patient characteristics influencing the choice of antithrombotic treatment for the prevention of stroke in non-valvular atrial fibrillation (AF) patients. To collect real world data on important outcome events of antithrombotic treatments for the prevention of stroke.

To Learn more

CW ID: 205755
Date Last Changed: February 27, 2015

Clinical Trial Snapshot

Phase
4
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Duration
3 Years
Facility Type
Out-Patient

Eligibility

Inclusion Criteria:

  • Age =>18 years at enrollment
  • Male or female patient (or legally acceptable representative) willing and able to provide written informed consent
  • Patient newly diagnosed (< 3 months prior to baseline visit) with non-valvular AF and at risk for stroke.

Exclusion Criteria:

  • Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention;
  • Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment in their lifetime;
  • AF with a generally reversible cause;
  • Patients with a medical condition other than atrial fibrillation for which chronic use of an oral anticoagulant (for example, a VKA) is indicated

More Info

Overall Status: Recruiting

Estimated Enrollment: 28,000 Subjects

Contact

Joan Galbraith BS, Rph, Pharmacy Quality and Clinical Research Manager
St. Alexius Medical Center
1310 East Main Ave., Suite 203
Bismarck, ND 58501
Phone: (701) 530-6954
Fax: (701) 530-6970

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.